(6aR,9R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide

Ergotamine; LC-ESI-ITFT; MS2; CE: 10; R=17500; [M+H]+

Ergotamine; LC-ESI-ITFT; MS2; CE: 20; R=17500; [M+H]+

Ergotamine; LC-ESI-ITFT; MS2; CE: 30; R=17500; [M+H]+

Ergotamine; LC-ESI-ITFT; MS2; CE: 40; R=17500; [M+H]+

Ergotamine; LC-ESI-ITFT; MS2; CE: 55; R=17500; [M+H]+

Ergotamine; LC-ESI-Q; MS; POS; 15 V

Ergotamine; LC-ESI-Q; MS; POS; 30 V

Ergotamine; LC-ESI-Q; MS; POS; 45 V

Ergotamine; LC-ESI-Q; MS; POS; 60 V

Ergotamine; LC-ESI-Q; MS; POS; 75 V

Ergotamine; LC-ESI-Q; MS; POS; 90 V